A Phase 2 Trial of Zanzalintinib in Advanced/Metastatic Bone Sarcomas (ZAMBONE)

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Phase 2 Trial of Zanzalintinib in Advanced/Metastatic Bone Sarcomas (ZAMBONE)	Neoplasms by Site, bone disorder, musculoskeletal system disorder, neoplasm	Recruiting	Phase 2	2026-09-25		NCT07193550

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Exelixis	77
M.D. Anderson Cancer Center	1145

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
The University of Texas M. D. Anderson Cancer Center	Houston	United States	88

Clinical trials